Live Webinar 25 Oct, 2pm EST Hosted by David Regan & Len Pagliaro PhD

Join Sona Nanotech’s CEO David Regan and CSO Len Pagliaro for a live webinar on which they will discuss the progress of Sona’s pre-clinical cancer Targeted Hyperthermia Therapy, which leverages Sona’s biocompatible Gold Nanorods.

This is a great opportunity to learn more about Sona’s proprietary technology and recently announced equity financing.

The session will end with a Q&A, so bring your questions and get them answered by David and Len.

Subscribe to Our Newsletter

Download the Company Presentation

Read or Download the Latest White Paper

The Case for Hyperthermia Thermal Therapy for Cancer - White Paper - Sona Nanotech

The Case for “Hyperthermia” Thermal Therapy for Cancer